The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Progress Toward Clinical Application of the Nitric Oxide–Releasing Diazeniumdiolates
Abstract
Diazeniumdiolates, compounds of structure R 1 R 2 NN(O)=NOR 3, which have also been called NONOates, have proven useful for treating an increasing diversity of medical disorders in relevant animal models. Here, I review the chemical features that make them such excellent starting points for designing materials capable of targeting reliable and controllable fluxes of bioactive NO for in vitro and in vivo applications. This is followed by a consideration of recent proof-of-concept studies that underscore what I believe to be the substantial clinical promise of such materials. Examples covered include progress toward inhibiting restenosis after angioplasty, preparing thromboresistant medical devices, reversing vasospasm, and relieving pulmonary hypertension. Together with a very recent report describing the beneficial effects of diazeniumdiolate therapy in a patient with acute respiratory distress syndrome, the results of the animal experiments support the prediction that a broad selection of problems in clinical medicine can be solved by judiciously mining the enormous variety of possible R 1 R 2 NN(O)=NOR 3 structures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric Oxide-Releasing Polymers Containing the [N(O)NO]-Group
Smith, D. J., Chakravarthy, D., Pulfer, S., Simmons, M. L., Hrabie, J. A., Citro, M. L., Saavedra, J. E., Davies, K. M., Hutsell, T. C., Mooradian, D. L., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950652b · Cited by 208
Self-citationSaavedra, J. E., Booth, M. N., Hrabie, J. A., Davies, K. M., & Keefer, L. K. (1999) · The Journal of Organic Chemistry · doi:10.1021/jo9901539 · Cited by 60
Self-citationNitric Oxide: Implications for Vascular and Endovascular Surgery
Vural, K. M., & Bayazit, M. (2001) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2001.1448 · Cited by 43
Cited by
The potential of nitric oxide releasing therapies as antimicrobial agents
Schairer, D. O., Chouake, J. S., Nosanchuk, J. D., & Friedman, A. J. (2012) · Virulence · doi:10.4161/viru.20328 · Cited by 573
Novel Role for Glutathione S-Transferase π
Townsend, D. M., Manevich, Y., He, L., Hutchens, S., Pazoles, C. J., & Tew, K. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805586200 · Cited by 298
Barraud, N., Storey, M. V., Moore, Z. P., Webb, J. S., Rice, S. A., & Kjelleberg, S. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2009.00098.x · Cited by 289
Nitric oxide–releasing macromolecular scaffolds for antibacterial applications
Yang, L., Feura, E. S., Ahonen, M. J. R., & Schoenfisch, M. H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800155 · Cited by 218
Polymer‐Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications
Jen, M. C., Serrano, M. C., van Lith, R., & Ameer, G. A. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201101707 · Cited by 194
Metadata
- Authors
- Keefer, L. K.
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2003-04
- Volume
- 43
- Issue
- 1
- Pages
- 585-607
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2128675236
- Cited by
- 189
- References
- 3
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress Toward Clinical Application of the Nitric Oxide–Releasing Diazeniumdiolates. https://app.cochat.ai/papers/10.1146/annurev.pharmtox.43.100901.135831
- The paper
- Keefer, L. K. (2003). Progress Toward Clinical Application of the Nitric Oxide–Releasing Diazeniumdiolates. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev.pharmtox.43.100901.135831
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.